LumibirdHAM:QTL -3.93%65 OCF Yield % is 5.33 as of Jun. 26, 2026, which is 16% below its 10-year median of 6.37. GuruFocus rates HAM:QTL with a GF Score™ of 65/100 and a GF Value™ of €16.31 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Lumibird ranks better than 70.23% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Lumibird's OCF Yield % or its related term are showing as below:
HAM:QTL'
s OCF Yield % Range Over the Past 10 Years
Min: 0.34 Med: 6.37 Max: 30.83
Current: 5.33
During the past 13 years, the highest OCF Yield % of Lumibird was 30.83%. The lowest was 0.34%. And the median was 6.37%.
HAM:QTL's OCF Yield % is ranked better than 70.23% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.07
vs HAM:QTL: 5.33
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Lumibird OCF Yield % Related Terms
Lumibird OCF Yield % Historical Data
* Premium members only.
The historical data trend for Lumibird's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Lumibird's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumibird OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Lumibird's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Lumibird's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumibird (HAM:QTL) has a OCF Yield % of 5.33 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Lumibird and its competitors. This is 16% below median its historical median of 6.37. Over the past decade, Lumibird's OCF Yield % has ranged from 0.34 to 30.83. According to the industry distribution chart, Lumibird ranks #64 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 29.8%.
Is Lumibird's OCF Yield % too high?
Lumibird's current OCF Yield % of 5.33 is 16% below median its 10-year median of 6.37. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 30.83. The Medical Diagnostics & Research industry median OCF Yield % is 1.07. Lumibird's value of 5.33 is 398.1% above this industry median. Based on the distribution chart, Lumibird ranks #64 out of 215 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Lumibird has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lumibird's OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Lumibird ranks #64 out of 215 companies for OCF Yield %. This puts Lumibird in the upper half of its industry. The industry median OCF Yield % is 1.07. Lumibird's value of 5.33 is 398.1% above this benchmark. Historically, Lumibird's own OCF Yield % has ranged from 0.34 to 30.83 over the past decade. While the company's 10-year median is 6.37 vs. the industry median of 1.07, Lumibird has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.07, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumibird's current OCF Yield % of 5.33 is 398.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Lumibird and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumibird's current OCF Yield % is 5.33, which is 16% below median its own 10-year median of 6.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumibird stock overvalued right now?
Based on GuruFocus' analysis, Lumibird (HAM:QTL) is currently considered Significantly Overvalued. The stock's GF Value™ is €16.31, compared to a current price of €23.25 — trading 42.6% above its estimated fair value. The current OCF Yield % is 5.33, which is 16% below median its 10-year median of 6.37 and 398.1% above the Medical Diagnostics & Research industry median of 1.07. Lumibird's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Lumibird (HAM:QTL), the current OCF Yield % is 5.33 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lumibird (HAM:QTL) Overvalued in 2026?
Based on GuruFocus' analysis, Lumibird stock appears to be overvalued.
The current stock price of €23.25 is trading 42.6% above its estimated GF Value™ of €16.31.
GuruFocus considers Lumibird to be Significantly Overvalued.
Key valuation signals for HAM:QTL:
OCF Yield %: 5.33 (16% below median its 10-year median of 6.37)
GF Value™: €16.31 vs. price of €23.25 (42.6% above fair value)
Industry Position: 398.1% above the Medical Diagnostics & Research median (#64 of 215)
No single metric tells the full story. See the HAM:QTL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lumibird, formerly Quantel SA is an enterprise engaged in the designing, manufacturing, and sale of scientific laser solutions. Scientific and industrial applications lasers used by research laboratories in the study of material, cleaning lasers, marking, measurement, and others. whereas, Medical applications include specialized lasers for ophthalmology, dermatology, and esthetics. The company generates a majority of its revenue from the scientific and industrial applications.
65GF Score
Get the complete analysis for HAM:QTL
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:QTL has been successfully added to your 
